Get With the Guidelines - Stroke PMT Comprehensive Measure Descriptions

Similar documents
Accreditation and Certification Guidelines

Level III Stroke Center Data Collection Requirements

Stroke Patient Management Tool (Standard, CM, Comprehensive) December 2014

Disease-Specific Care CERTIFICATION PROGRAM. Comprehensive Stroke

Stroke/VTE Quality Measure Build for Meaningful Use Stage 1

AHA/ASA Ischemic Stroke Performance Measures

ACUTE STROKE REGISTRY (NJASR) VERSION 2.0) (Continued)

The Clinical Evaluation of the Comatose Patient in the Emergency Department

Stroke Systems of Care

Texas Heart Attack and Stroke Data Collection Initiative: Data Update. Nimisha Bhakta, MPH Texas Heart Attack and Stroke Summit July 24, 2015

Therapeutic Management Options for. Acute Ischemic Stroke Anna Rosenbaum, MD

What s New in Stroke?

CLINICAL QUALITY MEASURES FINALIZED FOR ELIGIBLE HOSPITALS AND CRITICAL ACCESS HOSPITALS BEGINNING WITH FY 2014

TIME LOST IS BRAIN LOST. TARGET: STROKE CAMPAIGN MANUAL

Stroke Patient Management Tool (Standard) March 2016

STROKE OCCURRENCE SYMPTOMS OF STROKE

2016 International Stroke Conference Hot Topics Lori M. Massaro, MSN, CRNP Kari Moore, MSN, AGACNP-BC

NOVEL ANTICOAGULANTS

REMINDER: Please ensure all stroke and TIA patients admitted to hospital are designated as "Stroke Service" in Cerner.

Get With The Guidelines - Stroke PMT Special Initiatives Tab for Ohio Coverdell Stroke Program CODING INSTRUCTIONS Effective

New Treatments for Stroke Prevention in Atrial Fibrillation. John C. Andrefsky, MD, FAHA NEOMED Internal Medicine Review course May 5 th, 2013

Disease-Specific Care CERTIFICATION PROGRAM. Comprehensive Stroke

Advances in Stroke Care

Primary and Comprehensive Stroke Center Designation

Preparing Your Hospital for Comprehensive Stroke Certification. Authors: Julie Fussner BSN, RN, CPHQ, SCRN Claranne Mathiesen MSN, RN, CNRN

Cardiovascular Endpoints

UPDATED INCLUSION AND EXCLUSION CRITERIA FOR IV TPA ADMINISTRATION ACUTE STROKE TREATMENT: AN UPDATE GOALS OF TALK

Malmö Preventive Project. Cardiovascular Endpoints

STANDARDS OF PRACTICE

Approved: Acute Stroke Ready Hospital Advanced Certification Program

Acute Myocardial Infarction (the formulary thrombolytic for AMI at AAMC is TNK, please see the TNK monograph in this manual for information)

EMS Management of Stroke. Deaver Shattuck, M.D. Brian Wiseman, M.D. Keith Woodward, M.D.

Developing a Dynamic Team Approach to Stroke Care. Emergency Medical Services 2015

S9 Administer thrombolytic treatment in acute ischaemic stroke

Guidelines and Protocols

AR SAVES. INTRODUCTION AND UPDATES FOR ER PHYSICIANS. Nicolas Bianchi, MD. August 23 rd, 2012.

Cardiovascular Endpoints

Malmö Preventive Project. Cardiovascular Endpoints

Emerging therapies for Intracerebral Hemorrhage

GP workshop. Maria Fitzpatrick Nurse Consultant Kings College Stroke Centre

King County EMS Stroke Quality Improvement Program

STROKE PREVENTION AND TREATMENT MARK FISHER, MD PROFESSOR OF NEUROLOGY UC IRVINE

Ischaemic stroke 85% (85 in every 100 strokes)

Disclosures. Georgia Facts. Stroke System Models. Telestroke. The World is Flat : A Brief Future of Acute Stroke Care

HAAD JAWDA Quality KPI; waiting times. December 2015

Medical Management of Ischemic Stroke: An Update. Siddharth Sehgal, MD Medical Director, TMH Neuroscience Center

9/5/14. Objectives. Atrial Fibrillation (AF)

Review of the Stroke and VTE Measure Sets

A Patient s Guide to Antithrombotic Therapy in Atrial Fibrillation

Appendix L: HQO Year 1 Implementation Priorities

The New Jersey Acute Stroke Registry (NJASR) Version 2.0. Data Collection Manual. Effective Date: January 1, 2014

What is the Role of Telestroke in Stroke Systems of Care?

TPA, STROKE, & TELEMEDICINE. Improving utilization and improving outcomes in a constantly evolving field

convey the clinical quality measure's title, number, owner/developer and contact

Novel oral Anticoagulants, stroke and intracerebral hemorrhage

Stroke Coding Issues Presentation to: NorthEast Cerebrovascular Consortium

Overview of the TJC/CMS VTE Core Measures

The Quality of Stroke Care in Canada. Canadian Stroke Network

Current thrombolytic therapy in acute ischemic stroke is

Hospital-Based Sub-Acute Stroke Care and Secondary Prevention. Timothy Lukovits,, M.D.

Atrial Fibrillation, Chronic - Antithrombotic Treatment - OBSOLETE

How to manage a patient who needs thrombolysis in acute stroke, ablation or angioplasty/stenting? Janet M McComb Freeman Hospital Newcastle upon Tyne

Preparing for Comprehensive Stroke Certification

Clinical Audit in Hospital Authority. Dr Betty Young Convenor for Clinical Audit, Hospital Authority

How To Help A Stroke Patient

THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT

Stroke Care First week

STATEMENT OF STANDARD

Duration of Dual Antiplatelet Therapy After Coronary Stenting

Spontaneous Vertebral Artery Dissection. William Barsan, MD, FACEP

SCRN Medication Review. Susan M. Gaunt MS APRN ACNS-BC CCRN CNRN Gwinnett Medical Center


Treatment of Ischemic Stroke in the Neuro-ICU

STROKE PREVENTION IN ATRIAL FIBRILLATION

ALBERTA PROVINCIAL STROKE STRATEGY (APSS)

Boot Camp for Primary Stroke Certification. Sharon Eberlein RN MBA BSN NE-BC

Helen Fry Manager, Publications and Education Resources Joint Commission Resources

Basic Stroke for the New Recruit

Primary Stroke Certification

High Risk Emergency Medicine

Building an Emergency Response to Acute Stroke

Summary and general discussion

Preparing Your Hospital for Primary Stroke Certification Authors: Wendy J. Smith, BS, MA, RES, RCEP, RN Claranne Mathiesen, MSN, RN, CNRN

Code Stroke: Early Recognition and Emergency Management of the Acute Stroke Patient

Advanced Disease-Specific Care Certification Requirements for Comprehensive Stroke Center (CSC)

Stroke Thrombolysis Awareness. Initial patient assessment. Using F.A.S.T., Rosier, & NIHSS Tools

ENHANCING YOUR SKILLS IN STROKE QUALITY IMPROVEMENT & DATA ANALYSIS

Stroke An Overview. Dr Declan O Kane MD MRCP(UK) DipCompSci(Cantab) Consultant Physician VOL

Transcription:

Get With the Guidelines - Stroke PMT Comprehensive Measure s Last Updated January 2015 Print Measure s Door To Arterial Puncture Times (Comprehensive) Median Time to INR Reversal (Comprehensive) Median Time to Procoagulant Treatment for Intracerebral Hemorrhage (ICH) (Comprehensive) Thrombolysis in Cerebral Infarction (TICI) Post-Treatment Reperfusion Grade (Comprehensive) GWTG Comprehensive Stroke Pilot, Historic Measures: Intracranial Hemorrhagic Complication, Intra-arterial thrombolytic therapy alone (Comprehensive, Historic) Intracranial Hemorrhagic Complication, IV tpa alone (Comprehensive, Historic) Intracranial Hemorrhagic Complication, IV tpa + Intra-arterial thrombolytic therapy (Comprehensive, Historic) Median time to recanalization (Comprehensive, Historic) Modified Rankin Score (mrs) at 90 days (Comprehensive, Historic) National Institutes of Health Stroke Scale (NIHSS) Score on Arrival (Comprehensive, Historic) Nimodipine Treatment Initiated (Comprehensive, Historic) Procoagulant reversal agent initiated (Comprehensive, Historic) Severity Measurement on Arrival Intracerebral Hemorrhage (ICH) (Comprehensive, Historic) Severity Measurement on Arrival Subarachnoid Hemorrhage (SAH) (Comprehensive, Historic) Thrombolysis in Cerebral Infarction (TICI) Post-Treatment Reperfusion Grade 2B or 3 (Comprehensive, Historic) Note: *Data field is from the Post Discharge Follow-up Form Please note: Get With the Guidelines aggregate comparative data is intended for internal quality improvement. Permission is required from the American Heart Association and Quintiles for external presentation or publication of benchmark data. Door To Arterial Puncture Times (Comprehensive): Time from arrival to arterial puncture for ischemic stroke patients treated at my hospital with IA catheterbased treatment. Patients with a primary stroke diagnosis of ischemic stroke who received IA catheter based treatment at my hospital Age < 18 years IA catheter-based treatment at this hospital?: Yes Patients whose date/time of ED arrival and/or date/time of arterial puncture are blank, not documented, or N/A. Patients with a negative calculated time difference, when such calculation is relevant Patient location when stroke symptoms discovered: Stroke occurred after hospital arrival (in ED/Obs/inpatient) Arrival Date/Time: is blank or unknown or just MM/DD/YYYY Arterial puncture Date/Time: is blank or unknown or just MM/DD/YYYY Arterial puncture Date/Time < Arrival Date/Time During this hospital stay, was the patient enrolled in a clinical trial in

which patients with the same condition as the measure set were being studied?: Yes Display a.) Percent of patients in 10-minute intervals based on time from patient arrival at the ED to time of arterial puncture Was this patient admitted for the sole purpose of performance of elective carotid intervention?: Yes Arterial puncture Date/Time - Arrival Date/Time (A categorical graph with 19 bars: Eighteen 10-minute intervals from 0-180 min., one interval for >180 min.) b.) Statistics: Mean, Standard Deviation, Median, and Range of time from patient arrival at the ED to time of arterial puncture Median Time to INR Reversal (Comprehensive): Median time to INR reversal in patients treated with procoagulant reversal agent for warfarin related ICH Patients with intracerebral hemorrhage (ICH) with an INR 1.4 due to warfarin anticoagulation treated with procoagulant Final Clinical Diagnosis Related to Stroke: Intracerebral Hemorrhage Antiplatelet or Anticoagulant Medication(s) (medications prior to admission): Yes Anticoagulant: warfarin (Coumadin) INR: 1.4 Age < 18 years Comfort Measures Only documented on day of arrival or day after arrival Blank or missing procoagulant initiated date/time Blank or missing time for INR < 1.4 Is there documentation that a procoagulant reversal agent was initiated at this hospital?: Yes Age: < 18 When is the earliest documentation of comfort measures only?:day 0 or 1 Patients with a length of stay > 120 days Arrival Date/Time Date/Time Last Known Well > 24 hours Date/Time procoagulant initiated: is blank, unknown, or just MM/DD/YYYY If initial INR > 1.4 and treated with procoagulant, Date/Time first INR <= 1.4 after treatment: is blank, unknown, or just MM/DD/YYYY

Discharge Date Admission Date: > 120 days Patient location when stroke symptoms discovered: Stroke occurred after hospital arrival (in ED/Obs/inpatient) During this hospital stay, was the patient enrolled in a clinical trial in which patients with the same condition as the measure set were being studied?: Yes Display a.) Percent of patients in 20-minute intervals based on time from initiation of procoagulant to time INR <1.4 Was this patient admitted for the sole purpose of performance of elective carotid intervention?: Yes If initial INR > 1.4 and treated with procoagulant, Date/Time first INR <= 1.4 after treatment - Date/Time Procoagulant initiated (A categorical graph with 15 bars: Twelve 20-minute intervals from 0-260 min., one 10 min interval for 260-270, one interval for >270 min.) b.) Statistics: Mean, Standard Deviation, Median, and Range of time from arrival to time of administration of procoagulant Median Time to Procoagulant Treatment for Intracerebral Hemorrhage (ICH) (Comprehensive): Median time to treatment with a procoagulant reversal agent for warfarin related ICH Patients with intracerebral hemorrhage (ICH) with an INR 1.4 due to warfarin anticoagulation treated with procoagulant Final Clinical Diagnosis Related to Stroke: Intracerebral Hemorrhage Antiplatelet or Anticoagulant Medication(s) (medications prior to admission): Yes Anticoagulant: warfarin (Coumadin)] INR: 1.4 Age < 18 years Comfort Measures Only documented on day of arrival or day after arrival Blank or missing arrival date/time Is there documentation that a procoagulant reversal agent was initiated at this hospital?: Yes Age: < 18 When is the earliest documentation of comfort measures only?:day 0 or 1 Blank or missing procoagulant initiated date/time Patients with a length of stay > 120 days Arrival Date/Time: is blank, unknown, or just MM/DD/YYYY Date/time procoagulant initiated: is blank, unknown, or just

MM/DD/YYYY Discharge Date Admission Date: > 120 days Patient location when stroke symptoms discovered: Stroke occurred after hospital arrival (in ED/Obs/inpatient) During this hospital stay, was the patient enrolled in a clinical trial in which patients with the same condition as the measure set were being studied?: Yes Was this patient admitted for the sole purpose of performance of elective carotid intervention?: Yes Display a.) Percent of patients in 20-minute intervals based on time from arrival to time of initiation of procoagulant Date/Time procoagulant initiated - Arrival Date/Time (A categorical graph with 15 bars: Twelve 20-minute intervals from 0-260 min., one 10 min interval for 260-270, one interval for >270 min.) b.) Statistics: Mean, Standard Deviation, Median, and Range of time from arrival to time of administration of procoagulant Thrombolysis in Cerebral Infarction (TICI) Post-Treatment Reperfusion Grade (Comprehensive): Patients grouped by Thrombolysis in Cerebral Infarction (TICI) Post-Treatment Reperfusion Grade Patients with a diagnosis of ischemic stroke Patients undergoing catheter-based reperfusion therapy Age less than 18 years IA catheter-based treatment at this hospital?: Yes Length of stay > 120 days Patient location when stroke symptoms discovered: Stroke occurred after hospital arrival (in ED/Obs/inpatient) Discharge Date - Arrival Date > 120 days During this hospital stay, was the patient enrolled in a clinical trial in which patients with the same condition as the measure set were being studied?: Yes Was this patient admitted for the sole purpose of performance of elective carotid intervention?: Yes

Display Percent of patients in each TICI Grade Grade: 0 Grade: 1 Grade: 2a Grade: 2b Grade: 3 Patients with No Documented TICI grade Thrombolysis in Cerebral Infarction (TICI) Post-Treatment Reperfusion Grade: Grade: 0 Grade: 1 Grade: 2a Grade: 2b Grade: 3 Thrombolysis in Cerebral Infarction (TICI) Post-Treatment Reperfusion Grade: ND Intracranial Hemorrhagic Complication, Intra-arterial thrombolytic therapy alone (Comprehensive, Historic): Percent of ischemic stroke patients treated with IA catheter-based reperfusion therapy at this hospital that develop intracranial hemorrhagic complications within 36 hours of treatment Patients with a primary stroke diagnosis of ischemic stroke treated with intra-arterial thrombolytic therapy at my hospital IA catheter-based treatment at this hospital: Yes Age < 18 years Patients with a Length of Stay > 120days Patients treated with IV tpa at your hospital Patients that received IV tpa or IA tpa at an outside hospital prior to transfer to your hospital Patient location when stroke symptoms discovered: Stroke occurred after hospital arrival (in ED/Obs/inpatient) Discharge Date - Arrival Date > 120 days IV tpa initiated at this hospital?:yes IV tpa at an outside hospital?: Yes IA catheter-based treatment at outside hospital: Yes During this hospital stay, was the patient enrolled in a clinical trial in which patients with the same condition as the measure set were being studied?: Yes Patients with complications to thrombolytic therapy, defined as a 4 or more point increase in NIHSS accompanied by neuroimaging evidence of intracranial hemorrhage within 36 hours of treatment or death. Was this patient admitted for the sole purpose of performance of elective carotid intervention?: Yes Was there a clinical deterioration within 36 hours of the onset of treatment with IV or IA pharmacologic thrombolytic therapy, or endovascular reperfusion procedure?: Yes

( Highest NIHSS within 36 hours of IV or IA pharmacologic thrombolytic therapy, or endovascular reperfusion procedure NIHSS that most closely preceded treatment with IV or IA pharmacologic thrombolytic therapy, or endovascular reperfusion procedure: 4 Neuroimaging evidence of hemorrhagic complication within 36 hours? Yes Results of positive brain image: PH2 IVH SAH RIH ) If patient died, was there documentation that the patient s death was due to an intracranial hemorrhagic complication within 36 hours of the onset of treatment with IV or IA pharmacologic thrombolytic therapy, or endovascular procedure?: Yes Intracranial Hemorrhagic Complication, IV tpa alone (Comprehensive, Historic): Percent of ischemic stroke patients treated with IV tpa at this hospital that develop intracranial hemorrhagic complications within 36 hours of treatment Patients with a primary stroke diagnosis of ischemic stroke who received IV t-pa at my hospital Age < 18 years IV tpa initiated at this hospital?:yes Patients with a length of stay >120 days Patients that received IV tpa or IA tpa at an outside hospital prior to transfer to your hospital Patient location when stroke symptoms discovered: Stroke occurred after hospital arrival (in ED/Obs/inpatient) Patients receiving IA catheter based reperfusion at this hospital Discharge Date - Arrival Date > 120 days IV tpa at an outside hospital?: Yes IA catheter-based treatment at outside hospital: Yes IA catheter-based treatment at this hospital: Yes During this hospital stay, was the patient enrolled in a clinical trial in which patients with the same condition as the measure set were being studied?: Yes

Patients with complications to thrombolytic therapy, defined as a 4 or more point increase in NIHSS accompanied by neuroimaging evidence of intracranial hemorrhage within 36 hours of treatment or death. Was this patient admitted for the sole purpose of performance of elective carotid intervention?: Yes Was there a clinical deterioration within 36 hours of the onset of treatment with IV or IA pharmacologic thrombolytic therapy, or endovascular reperfusion procedure?: Yes ( Highest NIHSS within 36 hours of IV or IA pharmacologic thrombolytic therapy, or endovascular reperfusion procedure NIHSS that most closely preceded treatment with IV or IA pharmacologic thrombolytic therapy, or endovascular reperfusion procedure: 4 Neuroimaging evidence of hemorrhagic complication within 36 hours?: Yes Results of positive brain image: PH2 IVH SAH RIH ) If patient died, was there documentation that the patient s death was due to an intracranial hemorrhagic complication within 36 hours of the onset of treatment with IV or IA pharmacologic thrombolytic therapy, or endovascular procedure?: Yes Intracranial Hemorrhagic Complication, IV tpa + Intra-arterial thrombolytic therapy (Comprehensive, Historic): Percent of ischemic stroke patients treated with IV tpa followed by IA catheter-based reperfusion therapy at this hospital that develop intracranial hemorrhagic complications within 36 hours of treatment Patients with a primary stroke diagnosis of ischemic stroke treated with intra-arterial thrombolytic therapy at my hospital IV tpa initiated at this hospital?:yes Age < 18 years IA catheter-based treatment at this hospital: Yes Patients with a Length of Stay > 120 days Patients that received IV tpa or IA tpa at an outside hospital prior to transfer to your hospital Patient location when stroke symptoms discovered: Stroke occurred after hospital arrival (in ED/Obs/inpatient) Discharge Date - Arrival Date > 120 days IV tpa at an outside hospital?: Yes IA catheter-based treatment at outside hospital: Yes

During this hospital stay, was the patient enrolled in a clinical trial in which patients with the same condition as the measure set were being studied?: Yes Patients with complications to thrombolytic therapy, defined as a 4 or more point increase in NIHSS accompanied by neuroimaging evidence of intracranial hemorrhage within 36 hours of treatment or death. Was this patient admitted for the sole purpose of performance of elective carotid intervention?: Yes Was there a clinical deterioration within 36 hours of the onset of treatment with IV or IA pharmacologic thrombolytic therapy, or endovascular reperfusion procedure?: Yes ( Highest NIHSS within 36 hours of IV or IA pharmacologic thrombolytic therapy, or endovascular reperfusion procedure NIHSS that most closely preceded treatment with IV or IA pharmacologic thrombolytic therapy, or endovascular reperfusion procedure: 4 Neuroimaging evidence of hemorrhagic complication within 36 hours? Yes Results of positive brain image: PH2 IVH SAH RIH ) If patient died, was there documentation that the patient s death was due to an intracranial hemorrhagic complication within 36 hours of the onset of treatment with IV or IA pharmacologic thrombolytic therapy, or endovascular procedure?: Yes Median time to recanalization (Comprehensive, Historic): Median time from arrival to first radiographic image showing access of the occluded arterial segment with a microcatheter in acute ischemic stroke patients who undergo recanalization therapy Patients with a diagnosis of ischemic stroke Patients undergoing catheter-based reperfusion therapy Age less than 18 years IA catheter-based treatment at this hospital?: Yes Length of stay > 120 days Patient location when stroke symptoms discovered: Stroke occurred after hospital arrival (in ED/Obs/inpatient) Discharge Date - Arrival Date > 120 days During this hospital stay, was the patient enrolled in a clinical trial in which patients with the same condition as the

measure set were being studied?: Yes Display a.) Percent of patients in 20-minute intervals based on time from arrival to first radiographic image showing access of the occluded arterial segment. (A categorical graph with 14 bars: Was this patient admitted for the sole purpose of performance of elective carotid intervention?: Yes Date/Time of IA catheter-based treatment at this hospital - Arrival date/time Twelve 20 minute intervals from 0-240 min., one 30 minute interval for 240-270 min., one interval for >270 min.) b.) Statistics: Mean, Standard Deviation, Median, and Range of time from onset of stroke symptoms to time of administration of IV t-pa Modified Rankin Score (mrs) at 90 days (Comprehensive, Historic): Percent of ischemic stroke patients treated with IV or IA pharmacologic thrombolytic therapy or endovascular reperfusion procedure for whom a 90 day ( 75 days and 105 days) mrs is obtained via telephone or in-person and documented Patients with diagnosis of ischemic stroke Patients treated with IV tpa or who undergo an endovascular procedure ( IV tpa initiated at this hospital?:yes IV tpa at an outside hospital?: Yes IA catheter-based treatment at this hospital: Yes Age <18 Stroke occurred after hospital arrival (in ED/Obs/inpatient) Patients with a Length of Stay > 120 days ) Patient location when stroke symptoms discovered: Stroke occurred after hospital arrival (in ED/Obs/inpatient) Documented Modified Rankin Score at 90 days ( 75 days and 105 days) Discharge Date Admission Date: > 120 days *Post discharge Modified Rankin Scale performed (via telephone or in person)?: Yes (*If yes, Total Score: 0, 1, 2, 3, 4, or 5 *Date post discharge Modified Rankin Scale performed Discharge Date: 75 days and 105 days)

(*If yes, Total Score: 6 *Date post discharge Modified Rankin Scale performed Discharge Date: 105 days) Discharge Disposition: 6-Expired National Institutes of Health Stroke Scale (NIHSS) Score on Arrival (Comprehensive, Historic): Percent of ischemic stroke patients for whom an initial NIHSS is documented on arrival

Patients with a diagnosis of ischemic stroke Final clinical diagnosis related to stroke: Age < 18 years Ischemic Stroke Patients with a Length of Stay > 120 days Stroke symptoms resolved at time of presentation Patient location when stroke symptoms discovered: Stroke occurred after hospital arrival (in ED/Obs/inpatient) Discharge Date Admission Date: > 120 days Had stroke symptoms resolved at time of presentation?: Yes During this hospital stay, was the patient enrolled in a clinical trial in which patients with the same condition as the measure set were being studied?: Yes NIH Stroke scale performed prior to the initiation of thrombolytic therapy or performance of endovascular procedure or within 12 hours of arrival Actual Total Score is reported Was this patient admitted for the sole purpose of performance of elective carotid intervention?: Yes Initial NIH Stroke Scale: Yes Was the NIH Stroke Scale performed prior to the initiation of thrombolytic therapy or performance of endovascular procedure or within 12 hours of arrival?: Yes If Yes: Actual (NIHSS Total Score: is NOT blank Numeric between 0 and 42) Nimodipine Treatment Initiated (Comprehensive, Historic): Percent of subarachnoid hemorrhage (SAH) patients for whom nimodipine treatment was initiated within 24 hours of arrival Patients with a diagnosis of Subarachnoid hemorrhage Age <18 Final clinical diagnosis related to stroke: Subarachnoid hemorrhage

Stroke occurred after hospital arrival (in ED/Obs/inpatient) Patients with a Length of Stay > 120 days Patient location when stroke symptoms discovered: Stroke occurred after hospital arrival (in ED/Obs/inpatient) Patient discharged within 24 hours Comfort Measures Only documented on day of arrival or day after arrival Documented contraindication to oral nimodipine Discharge Date Arrival Date: >120 days Discharge Date/Time Arrival Date/Time: < 24 hours or 1 day When is the earliest documentation of comfort measures only?: Day 0 or 1 Nimodipine treatment administered in SAH at this hospital: NC During this hospital stay, was the patient enrolled in a clinical trial in which patients with the same condition as the measure set were being studied?: Yes Oral nimodipine initiated within 24 hours of hospital arrival. Was this patient admitted for the sole purpose of performance of elective carotid intervention?: Yes Nimodipine treatment initiated in SAH at this hospital?: Yes If yes, was nimodipine treatment initiated within 24 hours of arrival?: Yes Procoagulant reversal agent initiated (Comprehensive, Historic): Percent of patients with intracerebral hemorrhage (ICH) and an INR 1.4 due to warfarin anticoagulation that are treated with a procoagulant reveral agent Patients with intracerebral hemorrhage (ICH) with an INR 1.4 due to warfarin anticoagulation Final Clinical Diagnosis Related to Stroke: Intracerebral Hemorrhage Antiplatelet or Anticoagulant Medication(s) (medications prior to admission): Yes Anticoagulant: warfarin (Coumadin) INR: 1.4 Age < 18 years Comfort Measures Only documented on day of arrival or day after arrival Documented contraindication to procoagulant treatment Age: < 18 When is the earliest documentation of comfort measures only?: Day 0 or 1 Stroke occurred after hospital arrival (in Procoagulant treatment initiated in ICH at this hospital: NC

ED/Obs/inpatient) Patients with a Length of Stay > 120 days Patient location when stroke symptoms discovered: Stroke occurred after hospital arrival (in ED/Obs/inpatient) Discharge Date Admission Date: > 120 days During this hospital stay, was the patient enrolled in a clinical trial in which patients with the same condition as the measure set were being studied?: Yes Was this patient admitted for the sole purpose of performance of elective carotid intervention?: Yes Patients with procoagulant treatment initiated Procoagulant treatment initiated in ICH at this hospital?: Yes Severity Measurement on Arrival Intracerebral Hemorrhage (ICH) (Comprehensive, Historic): Percent of ICH patients with ICH Score on arrival Patients with a diagnosis of Intracerebral Hemorrhage Final clinical diagnosis related to stroke: Intracerebral hemorrhage Age <18 years Patients with a Length of Stay > 120 days Contraindication to ICH Score Patient location when stroke symptoms discovered: Stroke occurred after hospital arrival (in ED/Obs/inpatient) Discharge Date Admission Date: > 120 days ICH Score (ICH): NC ICH score recorded on arrival ICH score: Yes If yes, ICH score: Not Blank (numeric between 0 and 6) Severity Measurement on Arrival Subarachnoid Hemorrhage (SAH) (Comprehensive, Historic): Percent of SAH patients with Hunt and Hess Score on arrival

Patients with diagnosis of Subarachnoid hemorrhage Final clinical diagnosis related to stroke: Subarachnoid hemorrhage Age <18 Patients with a Length of Stay > 120 days Patients with a contraindication to having a score performed Patient location when stroke symptoms discovered: Stroke occurred after hospital arrival (in ED/Obs/inpatient) Discharge Date Admission Date: > 120 days Hunt and Hess Scale (SAH): NC Hunt and Hess score recorded on arrival Hunt and Hess Score recorded: Yes If yes, Hunt and Hess score: Not Blank (numeric between 1 and 5) Thrombolysis in Cerebral Infarction (TICI) Post-Treatment Reperfusion Grade 2B or 3 (Comprehensive, Historic): The proportion of patients undergoing catheter-based reperfusion therapy in whom the end of procedure TICI reperfusion grade is 2B or higher Patients with a diagnosis of ischemic stroke Patients undergoing catheter-based reperfusion therapy Age less than 18 years IA catheter-based treatment at this hospital?: Yes Patients with missing TICI grade Length of stay > 120 days Patient location when stroke symptoms discovered: Stroke occurred after hospital arrival (in ED/Obs/inpatient) Thrombolysis in Cerebral Infarction (TICI) Post-Treatment Reperfusion Grade: ND Discharge Date - Arrival Date > 120 days During this hospital stay, was the patient enrolled in a clinical trial in which patients with the same condition as the measure set were being studied?: Yes Was this patient admitted for the sole purpose of performance of elective carotid intervention?: Yes

TICI 2B or 3 Thrombolysis in Cerebral Infarction (TICI) Post-Treatment Reperfusion Grade: Grade 2B Thrombolysis in Cerebral Infarction (TICI) Post-Treatment Reperfusion Grade: Grade 3 NOT F USE WITHOUT PERMISSION - CONFIDENTIAL PROPRIETARY INFMATION OF QUINTILES THE AMERICAN HEART ASSOCIATION, INC.